RegenMed Welcomes Bert Mandelbaum, M.D. To Its Clinical/Scientific Advisory Board

September 18, 2023

RegenMed is proud to announce that Dr. Bert Mandelbaum has joined its Clinical/Scientific Advisory Board.

Dr. Mandelbaum is an internationally recognized orthopedics thought leader.  He serves on the Cedars-Sinai Kerlan-Jobe Institute board of directors, and is its co-chair of medical affairs.  Dr. Mandelbaum has held governing positions at many major orthopedic medical societies.  He also exercises senior medical responsibilities with U.S. major league soccer, USA Gymnastics, FIFA, and the US Men’s National Soccer Team (team physician), among others. 

RegenMed values highly the strategic support provided by Dr. Mandelbaum and his fellow C/SAB Members. It is particularly gratified by their shared belief in the clinical, professional and financial value inherent in real-world evidence, and the ability of Circles to deliver that value for healthcare providers and industry around the world.

CIRCLES ARTICLE

RegenMed Welcomes Bert Mandelbaum, M.D. To Its Clinical/Scientific Advisory Board

September 18, 2023

September 18, 2023

RegenMed is proud to announce that Dr. Bert Mandelbaum has joined its Clinical/Scientific Advisory Board.

Dr. Mandelbaum is an internationally recognized orthopedics thought leader.  He serves on the Cedars-Sinai Kerlan-Jobe Institute board of directors, and is its co-chair of medical affairs.  Dr. Mandelbaum has held governing positions at many major orthopedic medical societies.  He also exercises senior medical responsibilities with U.S. major league soccer, USA Gymnastics, FIFA, and the US Men’s National Soccer Team (team physician), among others. 

RegenMed values highly the strategic support provided by Dr. Mandelbaum and his fellow C/SAB Members. It is particularly gratified by their shared belief in the clinical, professional and financial value inherent in real-world evidence, and the ability of Circles to deliver that value for healthcare providers and industry around the world.

Read the latest

Follow usContact usSubscribeget started